Concepedia

Ming Yin

MY

47

Publications

3.8K

Citations

29

H-Index

1992

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The Ohio State University

Penn State Milton S. Hershey Medical Center

University of Washington

Fred Hutch Cancer Center

Ming Yin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

1992–2023

47

Publications

47

Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

Grant A. McArthur, Paul B. Chapman, Caroline Robert et al. · The Lancet Oncology · 2014 · 969 citations · Full text

, , +9

Endotoxin Exposure Is a Risk Factor for Asthma

Peter S. Thorne, Katarina Kulhánková, Ming Yin et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 331 citations · Full text

Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming

Yuanyuan Du, Jinlin Wang, Jun Jia et al. · Cell stem cell · 2014 · 316 citations · Full text

, , +12

Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study

Antoni Ribas, René González, Anna C. Pavlick et al. · The Lancet Oncology · 2014 · 293 citations

, , +7

Dog allergen (Can f 1) and cat allergen (Fel d 1) in US homes: Results from the National Survey of Lead and Allergens in Housing

Samuel J. Arbes, Richard D. Cohn, Ming Yin et al. · Journal of Allergy and Clinical Immunology · 2004 · 181 citations

, , +6

Rows per page

1–5 of 47